<DOC>
	<DOCNO>NCT02258984</DOCNO>
	<brief_summary>The purpose study evaluate impact Venus 1000 non-invasive CVP system management emergency department ( ED ) patient fluid sensitive condition .</brief_summary>
	<brief_title>Can Venus 1000 Help Clinicians Treat Patients With Severe Sepsis Acute Heart Failure ? The CVP Trial</brief_title>
	<detailed_description>The ability non-invasively , accurately , continuously measure CVP ass preload status ED patient could lead inclusion exist protocol ( similar EGDT ) , development novel protocol treatment patient fluid sensitive condition . The majority non-invasive measure preload , ultrasound inferior vena cava passive leg raise technique continuous measure require type effort skill part clinician . Continuous method assess preload include CVP measurement central venous catheter , esophageal Doppler monitoring , pulse contour analysis via arterial catheter monitoring , involve invasive procedure . The Venus CVP device non-invasive continuous monitoring capability . The data acquire project allow u determine whether emergency physician , practice , utilize information provide non-invasive CVP monitoring device assist management patient severe sepsis acute HF .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Age 18 year old great English speaking Clinical diagnosis : 1 ) Severe Sepsis , 2 ) Acute Heart Failure Traumatic injury Active bleed Pregnancy Prisoners Central venous catheter placement internal jugular subclavian vein Bilateral external jugular vein catheterization Concurrent enrollment interventional clinical trial may affect subject treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>